CAPURSO, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 565
EU - Europa 557
AS - Asia 177
SA - Sud America 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.305
Nazione #
US - Stati Uniti d'America 561
SE - Svezia 332
CN - Cina 119
IT - Italia 114
IE - Irlanda 24
FI - Finlandia 21
HK - Hong Kong 15
DE - Germania 13
FR - Francia 13
IN - India 13
GB - Regno Unito 11
RU - Federazione Russa 8
SG - Singapore 8
TW - Taiwan 8
IR - Iran 6
CA - Canada 4
TR - Turchia 4
BR - Brasile 3
CZ - Repubblica Ceca 3
PT - Portogallo 3
UA - Ucraina 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
ES - Italia 2
JP - Giappone 2
PL - Polonia 2
EU - Europa 1
GR - Grecia 1
MO - Macao, regione amministrativa speciale della Cina 1
NL - Olanda 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
Totale 1.305
Città #
Ashburn 96
Shanghai 92
Lawrence 86
Princeton 86
New York 62
Milan 34
Dublin 24
Washington 22
Helsinki 20
Seattle 15
Hong Kong 13
Rome 12
London 10
Pune 10
Los Angeles 8
Vaprio d'Adda 8
Columbus 7
Chang-hua 6
Mountain View 6
Verona 6
Carlsbad 5
Ancona 4
Bergamo 4
St Petersburg 4
Genoa 3
Kyiv 3
Oakville 3
Paris 3
Strasbourg 3
Villa Guardia 3
Acireale 2
Austin 2
Barcelona 2
Bari 2
Berlin 2
Bern 2
Cambridge 2
Canberra 2
Civitavecchia 2
Cordenons 2
Kish 2
Krakow 2
Landshut 2
Lecco 2
Moscow 2
New Delhi 2
Nizhniy Novgorod 2
Pisa 2
Porto 2
Redwood City 2
Rio de Janeiro 2
Romainville 2
Saint-Denis 2
San Maurizio Canavese 2
Santa Clara 2
Singapore 2
Stuttgart 2
Taipei 2
Teramo 2
Tulln 2
Turin 2
Arezzo 1
Boardman 1
Borås 1
Brescia 1
Bucharest 1
Buffalo 1
Campodolcino 1
Cassano d'Adda 1
Cheyenne 1
Chiaravalle 1
Chicago 1
Kolkata 1
Lappeenranta 1
Las Vegas 1
Macao 1
Minamiedo 1
Minatomirai 1
Monza 1
Mortara 1
Naaldwijk 1
Naples 1
Padova 1
Pombal 1
Portsmouth 1
San Mateo 1
Shenzhen 1
St. John's 1
Tarlac City 1
Torino 1
Uberaba 1
Valenciennes 1
Venezia 1
Westminster 1
Totale 753
Nome #
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 53
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 29
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 22
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 22
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 21
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 20
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 19
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 19
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk 19
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 18
Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 18
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 18
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 17
Infection Control Practices and Outcomes of Endoscopy Units in the Lombardy Region of Italy: A Survey From the Italian Society of Digestive Endoscopy During COVID-19 Spread 17
Urgent manifestations of immunoglobulin G4-related disease 17
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. 17
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures 17
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 17
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 17
European evidence-based guidelines on pancreatic cystic neoplasms 16
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 16
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 15
Consensus guidelines on severe acute pancreatitis 15
Genome-wide association study identifies an early onset pancreatic cancer risk locus 15
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 15
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 15
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 14
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency 14
Update on gastroenteropancreatic neuroendocrine tumors 14
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 14
Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence? 14
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 14
Artificial intelligence in EUS for autoimmune pancreatitis: Bias and real life 14
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 13
Delay in Pancreatic Endoscopic Ultrasound during the COVID-19 Pandemic in a Pancreas/Tertiary Referral Center 13
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 13
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer 13
Slow-pull compared to suction technique for EUS-guided sampling of pancreatic solid lesions: a meta-analysis of randomized controlled trials 13
Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis 13
How to get away with COVID-19: endoscopy during post-peak pandemic. A perspective review 13
The impact of nutritional status on pancreatic cancer therapy 12
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 12
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 12
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 12
Endosonography-guided radiofrequency ablation in pancreatic diseases: Time to fill the gap between evidence and enthusiasm 12
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 12
Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: An international multicentre study 12
Machine learning for the prediction of post-ERCP Pancreatitis risk: A proof-of-concept study 12
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk 11
The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial: Protocol of the EFFORT randomized trial: dietary fat reduction and pancreatitis recurrence 11
Risk factors for the occurrence of ampullary tumors: A case-control study 11
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 11
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 11
Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations 11
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 11
Diagnostic performance of Endoscopic Ultrasound Through-The-Needle microforceps Biopsy (EUS-TTNB) of pancreatic cystic lesions: a systematic review with meta-analysis 11
Chronic Asymptomatic Pancreatic Hyperenzymemia (CAPH): Meta-analysis of pancreatic findings at second-level imaging 11
MYC up-regulation confers resistance to everolimus and establishes vulnerability to cyclin dependent kinase inhibitors in pancreatic neuroendocrine neoplasms cells 11
Genetic and non-genetic risk factors for early-onset pancreatic cancer 10
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 10
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 10
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 10
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 10
Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study 10
Correction to: Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature? (Clinical and Translational Gastroenterology, (2018), 9, 6, (158), 10.1038/s41424-018-0026-3) 10
Pancreatic cyst surveillance imposes low psychological burden 10
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 10
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 9
ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma 9
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 9
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 9
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 9
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer 9
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. 9
SECONDARY CANCERS IN PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS (IPMN): PRELIMINARY RESULTS OF A PROSPECTIVE MULTICENTRE ITALIAN STUDY 9
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study 9
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 9
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients with Autoimmune Pancreatitis: Systematic Review and Meta-analysis 8
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 8
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 8
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 8
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 8
Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 8
RISK FACTORS FOR INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM (IPMN) OF THE PANCREAS: PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN MULTICENTRE CASE-CONTROL STUDY 8
Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study 8
Needle-knife fistulotomy vs. standard biliary sphincterotomy for choledocholithiasis: common bile duct stone recurrence and complication rate 8
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas 8
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis 8
Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival 8
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 7
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression 7
Factors associated with the risk of patients and healthcare workers to develop COVID-19 during digestive endoscopy in a high-incidence area 7
Immunomodulatory Effects of Endoscopic Ultrasound-Guided Thermal Ablation in Patients with Pancreatic Ductal Adenocarcinoma 7
Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry 7
Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. 7
Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 7
Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms 7
Focal immune-related pancreatitis occurring after treatment with programmed cell death 1 inhibitors: a distinct form of autoimmune pancreatitis? 7
Patient-reported experience measure in pancreatobiliary endoscopy: a systematic review to highlight areas for improvement 7
Pancreatic cystic neoplasms in 2018: The final cut 7
Totale 1.252
Categoria #
all - tutte 27.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 4 0 0 0 0 0 30 0 0 0 0 0
2020/202145 0 0 0 0 26 15 3 0 1 0 0 0
2021/202270 0 0 2 29 9 2 4 3 10 3 2 6
2022/2023646 198 114 47 1 10 81 78 63 31 2 12 9
2023/2024889 48 36 81 256 70 149 46 111 18 29 45 0
Totale 1.690